KKR Converts Remaining Stake in Coty (COTY) into Nearly 20M Common Shares

Coty Inc. (COTY) PT Raised to $11.50 at DA Davidson

November 9, 2021 7:01 AM EST

DA Davidson analyst Linda Bolton Weiser raised the price target on Coty Inc. (NYSE: COTY) to $11.50 (from $10.50) while maintaining a Neutral rating.

The analyst commented, "Coty's F1Q22 sales slightly exceeded consensus and were +22% vs. an easy COVID-impacted comp of -20%. EBITDA... More

Coty Inc. (COTY) PT Raised to $12 at Deutsche Bank

November 9, 2021 6:43 AM EST

Deutsche Bank analyst Faiza Alwy raised the price target on Coty Inc. (NYSE: COTY) to $12.00 (from $11.00) while maintaining a Buy rating.... More

UPDATE: Raymond James Upgrades Coty Inc. (COTY) to Outperform, 'Party Just Getting Started'

November 9, 2021 6:39 AM EST

(Updated - November 9, 2021 6:45 AM EST)

Raymond James analyst Olivia Tong upgraded Coty Inc. (NYSE: COTY) from Market Perform to Outperform with a price target of $14.00.

The analyst comments "We are upgrading shares of COTY to Outperform from Market... More

Coty Inc. (COTY) PT Raised to $13 at Stifel

November 8, 2021 5:37 PM EST

Stifel analyst Mark S. Astrachan raised the price target on Coty Inc. (NYSE: COTY) to $13.00 (from $11.00) while maintaining a Hold rating.

The analyst commented, "We increase F2022-F2023 adjusted EBITDA estimates by 4%-5% following solid F1Q22 results. We also lift... More

Pre-Open Stock Movers 11/08: (AUTL) (TTD) (BLNK) Higher; (EHTH) (BLUE) (TSLA) Lower (more...)

November 8, 2021 8:50 AM EST

Pre-Open Stock Movers:

Autolus Therapeutics plc (Nasdaq: AUTL) 27.2% HIGHER; announced that the two companies have entered into a strategic collaboration and financing agreement under which funds managed by Blackstone (NYSE: BX) will provide up to $250 million in equity and product financing to support Autolus advancement of its CD19 CAR T cell investigational therapy product candidate, obecabtagene autoleucel (obe-cel), as well as next generation product therapies of obe-cel in B-cell malignancies.

eHealth (NASDAQ: EHTH) 22.5%... More

Duty-free demand, cost cuts drive Coty's rosy forecast

November 8, 2021 6:50 AM EST

By Aditi Sebastian and Praveen Paramasivam

(Reuters) - Coty Inc forecast annual earnings largely above estimates on Monday, as the cosmetics maker benefits from cost cuts to ward off inflation impacts and a revival in demand for its products at airport duty-free stores.

Shares jumped about 13% in morning trade as quarterly net revenue in its prestige segment increased 35.1% to $870.7 million.

Coty, which is grappling with industry-wide supply-chain bottlenecks, said it is managing cost pressures through high-end product... More

Coty (COTY) Tops Q1 EPS by 5c, Offers FY Guidance

November 8, 2021 6:34 AM EST

Coty (NYSE: COTY) reported Q1 EPS of $0.08, $0.05 better than the analyst estimate of $0.03. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.36 billion.

GUIDANCE:

Coty sees FY2022 EPS of $0.19-$0.23, versus the consensus of... More

Coty (COTY) Sells 4.7% Stake in Wella to KKR

November 8, 2021 6:31 AM EST

Coty Inc. (NYSE: COTY) today announced a definitive agreement to sell an approximate 4.7% stake in Wella to KKR in exchange for the redemption of approximately 56% of KKRs remaining convertible preferred shares in Coty. This transaction reduces Cotys total shareholding in the professional beauty company to approximately 25.9%. The structure and terms of the transaction are consistent with the previous transaction announced on October 1, 2021 in which Coty agreed to exchange a 9% stake in Wella for the equivalent of approximately 47 million... More